• Mashup Score: 1
    Using Cryptocurrency To Develop Orphan Drugs for Rare Diseases - 12 month(s) ago

    Alok Tayi, PhD, Founder and CEO of Vibe Bio, gives an overview of his company, its mission and objectives, and how it plans to advance the development of rare disease therapies.

    Source: CheckRare
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CheckRare
      CheckRare

      Alok Tayi, Ph.D., Founder and CEO of Vibe Bio, gives an overview of his company, its mission and objectives, and how it plans to advance the development of rare disease therapies. @VibeBio @Chelseashopela1 https://t.co/1xZnLUwOrS #VibeBio #Lafora #ChelseasHope #rarediseases

  • Mashup Score: 1
    Using Cryptocurrency To Develop Orphan Drugs for Rare Diseases - 1 year(s) ago

    Alok Tayi, PhD, Founder and CEO of Vibe Bio, gives an overview of his company, its mission and objectives, and how it plans to advance the development of rare disease therapies.

    Source: CheckRare
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CheckRare
      CheckRare

      Alok Tayi, Ph.D., Founder and CEO of Vibe Bio, gives an overview of his company, its mission and objectives, and how it plans to advance the development of rare disease therapies. @VibeBio @Chelseashopela1 https://t.co/1xZnLUwOrS #VibeBio #Lafora #ChelseasHope #rarediseases

  • Mashup Score: 1
    Using Cryptocurrency To Develop Orphan Drugs for Rare Diseases - 1 year(s) ago

    Alok Tayi, PhD, Founder and CEO of Vibe Bio, gives an overview of his company, its mission and objectives, and how it plans to advance the development of rare disease therapies.

    Source: CheckRare
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CheckRare
      CheckRare

      Alok Tayi, Ph.D., Founder and CEO of Vibe Bio, gives an overview of his company, its mission and objectives, and how it plans to advance the development of rare disease therapies. @VibeBio @Chelseashopela1 https://t.co/1xZnLUxmhq #VibeBio #Lafora #ChelseasHope #rarediseases

  • Mashup Score: 0
    Using Cryptocurrency To Develop Orphan Drugs for Rare Diseases - 1 year(s) ago

    Alok Tayi, PhD, Founder and CEO of Vibe Bio, gives an overview of his company, its mission and objectives, and how it plans to advance the development of rare disease therapies.

    Source: CheckRare
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CheckRare
      CheckRare

      Alok Tayi, Ph.D., Founder and CEO of Vibe Bio, gives an overview of his company, its mission and objectives, and how it plans to advance the development of rare disease therapies. @VibeBio @Chelseashopela1 https://t.co/1xZnLUwOrS #VibeBio #Lafora #ChelseasHope #rarediseases

  • Mashup Score: 0
    Using Cryptocurrency To Develop Orphan Drugs for Rare Diseases - 1 year(s) ago

    Alok Tayi, PhD, Founder and CEO of Vibe Bio, gives an overview of his company, its mission and objectives, and how it plans to advance the development of rare disease therapies.

    Source: CheckRare
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CheckRare
      CheckRare

      Alok Tayi, Ph.D., Founder and CEO of Vibe Bio, gives an overview of his company, its mission and objectives, and how it plans to advance the development of rare disease therapies. @VibeBio @Chelseashopela1 https://t.co/1xZnLUwOrS #VibeBio #Lafora #ChelseasHope #rarediseases

  • Mashup Score: 0
    Using Cryptocurrency To Develop Orphan Drugs for Rare Diseases - 1 year(s) ago

    Alok Tayi, PhD, Founder and CEO of Vibe Bio, gives an overview of his company, its mission and objectives, and how it plans to advance the development of rare disease therapies.

    Source: CheckRare
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CheckRare
      CheckRare

      Alok Tayi, Ph.D., Founder and CEO of Vibe Bio, gives an overview of his company, its mission and objectives, and how it plans to advance the development of rare disease therapies. @VibeBio @Chelseashopela1 https://t.co/1xZnLUwOrS #VibeBio #Lafora #ChelseasHope #rarediseases